As of 2026-06-18, the Relative Valuation of Flexion Therapeutics Inc (FLXN) is (95.33) USD. This relative valuation is based on P/E multiples. With the latest stock price at 25.13 USD, the upside of Flexion Therapeutics Inc based on Relative Valuation is -479.3%.
The range of the Relative Valuation is (87.48) - (96.56) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 15.6x - 17.2x | 17.1x |
| Forward P/E multiples | 15.2x - 18.2x | 16.9x |
| Fair Price | (87.48) - (96.56) | (95.33) |
| Upside | -448.1% - -484.2% | -479.3% |
| Date | P/E |
| 2026-06-12 | -4.47 |
| 2026-06-11 | -4.46 |
| 2026-06-10 | -4.43 |
| 2026-06-09 | -4.44 |
| 2026-06-08 | -4.44 |
| 2026-06-05 | -4.43 |
| 2026-06-04 | -4.46 |
| 2026-06-03 | -4.45 |
| 2026-06-02 | -4.46 |
| 2026-06-01 | -4.46 |
| 2026-05-29 | -4.47 |
| 2026-05-28 | -4.46 |
| 2026-05-27 | -4.49 |
| 2026-05-26 | -4.48 |
| 2026-05-22 | -4.47 |
| 2026-05-21 | -4.47 |
| 2026-05-20 | -4.46 |
| 2026-05-19 | -4.43 |
| 2026-05-18 | -4.44 |
| 2026-05-15 | -4.45 |
| 2026-05-14 | -4.47 |
| 2026-05-13 | -4.46 |
| 2026-05-12 | -4.46 |
| 2026-05-11 | -4.47 |
| 2026-05-08 | -4.48 |
| 2026-05-07 | -4.47 |
| 2026-05-06 | -4.48 |
| 2026-05-05 | -4.47 |
| 2026-05-04 | -4.46 |
| 2026-05-01 | -4.47 |
| 2026-04-30 | -4.47 |
| 2026-04-29 | -4.45 |
| 2026-04-28 | -4.47 |
| 2026-04-27 | -4.47 |
| 2026-04-24 | -4.59 |
| 2026-04-23 | -4.59 |
| 2026-04-22 | -4.59 |
| 2026-04-21 | -4.58 |
| 2026-04-20 | -4.59 |
| 2026-04-17 | -4.59 |
| 2026-04-16 | -4.57 |
| 2026-04-15 | -4.58 |
| 2026-04-14 | -4.58 |
| 2026-04-13 | -4.57 |
| 2026-04-10 | -4.55 |
| 2026-04-09 | -4.57 |
| 2026-04-08 | -4.56 |
| 2026-04-07 | -4.52 |
| 2026-04-06 | -4.53 |
| 2026-04-02 | -4.51 |